New recommendations issued for pneumococcal vaccine in high-risk adults

Real-world effectiveness data showed semaglutide reduced the risk of major kidney disease events by 26%.

Marta Wosinska, PhD, and Joey Mattingly, PharmD, MBA, PhD, joined Drug Topics to help us understand how pharmaceutical tariffs could potentially impact the pharmacy industry.

Researchers conducted a systematic review and meta-analysis to estimate vaccine coverage and identify factors associated with vaccination among forcibly displaced, pediatric populations.

In this episode, Natalie DiPietro Mager, PharmD, PhD speaks with David Bright, PharmD, MBA, professor at Ferris State University College of Pharmacy.

Researchers conducted a review that provided updated evidence regarding the pneumococcal disease burden, the evolution of pneumococcal vaccines, and the latest immunization strategies.

Researchers wanted to address the potential impact of pharmacist-led influenza immunization services on vaccine uptake in older adults living in Denmark.